Moreover, continuation of ACE inhibitor/ARB outpatient treatment after hospitalization has beneficial effects on COVID-19 outcomes [163], whereas discontinuing treatment can be harmful [164,165,166,167,168]. This evidence concerns the gene ACE and COVID-19.